Pfizer to ask for emergency authorization for its COVID vaccine today

Pfizer and BioNTech are planning to ask the Food and Drug Administration for emergency authorization for their COVID-19 vaccine today. It will be the first coronavirus vaccine to try to get regulatory approval in the U.S.Q3 2020 hedge fund letters, conferences and morePfizer, BioNTech to seek emergency authorization for vaccineThe two companies issued a statement saying that their COVID-19 vaccine candidate, which has officially been tagged as BNT162b2, could be available to high-risk populations in the U.S. by mid- to late December. The vaccine requires two injections given a few weeks apart….

Read More

HEDGE accordingly